Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-13 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-13 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-13 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-12 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-12 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | SCN3A | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
mRNA | KIAA1468 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |